Skip to content

Clinical trials

Withdrawn Lung Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Withdrawn Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091
20183
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
GlaxoSmithKline1
McMaster University1
Spectrum Pharmaceuticals, Inc1
Sunnybrook Health Sciences Centre1
University Health Network, Toronto1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms7
Carcinoma, Non-Small-Cell Lung4
Adenocarcinoma of Lung2
Anxiety Disorders1
Nausea1
Neoplasm, Residual1
Neoplasms1
Urinary Retention1
Urinary Tract Infections1
Vomiting1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.